Fused heteroaryl derivatives
US6608053B2 · kind B2 · utility
77Cited by
3References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 26, 2001 |
| Grant date | Aug 19, 2003 |
| Priority date | — |
| Expiry date | Apr 26, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a pharmaceutical composition which is useful as a phosphatidylinositol 3 kinase (PI3K) inhibitor and an antitumor agent, and it provides a novel bicyclic or tricyclic fused heteroaryl derivative or a salt thereof which possesses an excellent PI3K inhibiting activity and cancer cell growth inhibiting activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.